ACS and Stable Angina Drugs Flashcards
Nitrates
- STABLE ANGINA DRUG
- Release NO and activate guanylyl cyclase, this makes GMP and causes vasodilation
- Significant first pass metabolism (Given by sublingual etc…)
- Risk of developing a tolerance (thiol def., increased superoxide, activation of RAAS…)
- Adverse effects: headaches, ortho hypotension, increased renal Na+ and H2O absorption
- DO NOT COMBINE WITH ED DRUGS
Nitroglycerin
- STABLE ANGINA DRUG
- type of nitrate
Isosorbide dinitrate
- STABLE ANGINA DRUG
- type of nitrate
Isosorbide mononitrate
- STABLE ANGINA DRUG
- type of nitrate
Calcium Channel Blockers
- STABLE ANGINA DRUG
- prevent myosin light chain function
- 2 types: dihydropyridines and cardioactive CCBs
- Dihydropyridines: work on vascular smooth muscle
- Cardioactive CCBs: work on vascular smooth muscle, cardiac muscle, and cardiac pacemaker cells
Amlodipine
- STABLE ANGINA DRUG
- dihydropyridine CCB
- long acting
Nifedipine
- STABLE ANGINA DRUG
- dihydropyridine CCB
- short acting
Nicardipine
- STABLE ANGINA DRUG
- dihydropyridine CCB
- short acting
Diltiazem
- STABLE ANGINA DRUG
- Cardioactive CCB
Varapamil
- STABLE ANGINA DRUG
- Cardioactive CCB
β-Blockers
- STABLE ANGINA DRUG
- Decrease adrenergic stimulation to heart, and also decrease BP leading to reduced afterload
Propranolol
- STABLE ANGINA DRUG
- β-Blocker
Nadolol
- STABLE ANGINA DRUG
- β-Blocker
Metoprolol
- STABLE ANGINA DRUG
- β-Blocker
Atenolol
- STABLE ANGINA DRUG
- β-Blocker
Ranolazine
- STABLE ANGINA DRUG
- Blocks the late Na+ current
- Normalizes the repolarization of cardiac myocytes
- May reduce diastolic tension and compression of coronary vessels in diastole
- Used in stable angina that is refractory to standard meds
Antiplatelet drugs
- ACS DRUG
- inhibit platelet function
- used to prevent white thrombi in arteries
Anticoagulants
- ACS DRUG
- regulate functions and synthesis of clotting factors
- prevent red thrombi from forming in veins
Thrombolytics
- ACS DRUG
- destroy blood clots after they have formed
- re-establish blood flow
Aspirin
- ACS DRUG (antiplatelet)
- irreversible inhibition of COX to prevent production of TxA2
Clopidogrel
- ACS DRUG (antiplatelet)
- P2Y12 (ADP) receptor blocker
- inhibits a Gi and therefore increases levels of cAMP, which prevents platelet aggregation
- nonfunctional CYP2C19 allele renders drug inactive (50% chinese, 34%AA, 25% cauc.)
Prasugrel
- ACS DRUG (antiplatelet)
- P2Y12 (ADP) receptor blocker
- inhibits a Gi and therefore increases levels of cAMP, which prevents platelet aggregation
Ticagrelor
- ACS DRUG (antiplatelet)
- P2Y12 (ADP) receptor blocker
- inhibits a Gi and therefore increases levels of cAMP, which prevents platelet aggregation
Abciximab
- ACS DRUG (antiplatelet)
- GP IIB/IIIA inhibitor
- risk of thrombocytopenia
Eptifibatide
- ACS DRUG (antiplatelet)
- GP IIB/IIIA inhibitor
Tirofiban
- ACS DRUG (antiplatelet)
- GP IIB/IIIA inhibitor
Alteplase
- ACS DRUG (thrombolytic)
- Tissue Plasminogen Activator
Reteplase
- ACS DRUG (thrombolytic)
- Tissue Plasminogen Activator
Tenecteplase
- ACS DRUG (thrombolytic)
- Tissue Plasminogen Activator
Streptokinase
-ACS DRUG (thrombolytic)